Skip to main content
. 2023 Sep 2;14:5332. doi: 10.1038/s41467-023-40813-w

Table 2.

Treatment-related adverse events. Listed as the number of patients experiencing each adverse event

Treatment-related adverse event Grade 1 Grade 2 Grade 3
Anemia 8 2 0
Hyperthyroidism 2 1 0
Hypothyroidism 1 2 0
Diarrhea 3 0 0
Nausea 2 2 0
Edema 1 1 0
Fatigue 7 2 0
Chest Pain 0 1 0
LFT abnormality 3 0 1
Lymphopenia 3 6 3
Neutropenia 1 0 0
Bronchial infection 0 1 0
Thrombocytopenia 3 0 0
Decreased WBC 6 0 0
Anorexia 1 1 0
Electrolyte abnormalities 2 0 0
Dizziness 2 0 0
Headache 1 0 0
Peripheral neuropathy 1 0 0
Dyspnea 2 1 0
Urinary Frequency 1 0 0
Pneumonitis 1 1 0
Cough 0 2 0
Rash 3 1 1
Musculoskeletal 2 0 2
Conjunctivitis 0 1 0
Ear disorder 0 1 0